Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
- 1 November 1975
- journal article
- Vol. 22 (2), 279-84
Abstract
Macrophage migration inhibition (MMI) tests have been carried out using lymphocytes from twenty-six patients with malignant disease and from twenty-two other subjects. The antigens used were the same as those employed in the macrophage electrophoretic mobility (MEM) test. The results indicate that the inforation obtained using the MMI test is similar to that found with the MEM test.This publication has 14 references indexed in Scilit:
- MACROPHAGE-ELECTROPHORETIC-MOBILITY (M.E.M.) TEST FOR MALIGNANT DISEASE: An Independent ConfirmationThe Lancet, 1972
- Lymphocyte sensitivity in cancer.BMJ, 1971
- Specific Lymphocyte Sensitization in Cancer: Is There a Common Antigen in Human Malignant Neoplasia?BMJ, 1971
- LYMPHOCYTE SENSITISATION: AN IN-VITRO TEST FOR CANCER ?The Lancet, 1970
- Tissue Typing Using a Routine One‐Step Lymphocyte Separation ProcedureBritish Journal of Haematology, 1970
- Sensitization of Blood Lymphocytes to Possible Antigens in Neurological DiseaseEuropean Neurology, 1970
- Mechanism of a Reaction in Vitro Associated with Delayed-Type HypersensitivityScience, 1966
- DELAYED HYPERSENSITIVITY IN VITRO .I. SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS1964
- In vitro Cell Migration as a Model for Delayed Hypersensitivity.Experimental Biology and Medicine, 1962